The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMWG.L Regulatory News (MWG)

  • There is currently no data for MWG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Increase in Orders for Reagent Consumables

30 Mar 2020 07:00

RNS Number : 9531H
Modern Water PLC
30 March 2020
 

AIM share code: MWG

30 March 2020

 

Modern Water PLC

 

("Modern Water" or "Company")

 

UK bacteria production to detect water contamination begins amid COVID-19 public health crisis

 

Orders of water contamination detection consumables up 46% in Q1 2020 compared to Q1 2019

 

Modern Water announces that orders for water contamination detection bacteria consumables have increased by 46% in Q1 2020 compared to Q1 2019. Two months of stock have been shipped in the last two weeks amid growing demand, believed to be connected to the global COVID 19 public health crisis, from existing customers across Spain, Italy and China. Production by Integumen plc, of Modern Water's monitoring bacteria reagent has begun at the University of York, UK, 6 weeks ahead of the originally planned production date.

 

Simon Humphrey, CEO of Modern Water, commented:

"In the last two months we have been able to adapt quickly to our revenue sharing business model which will now give us access to higher volumes on two continents. With production laboratories in Delaware, US and our partner Integumen's production facilities coming on stream in York, UK, we have removed the continuity of supply risk for our customers. This puts Modern Water in a strong position to address the increased demand in a shorter time period, assuring clients as we reduce the order backlog and meet their growing need for our water monitoring products and services."

 

Regulatory requirements

Below are countries in which Modern Water Microtox Acute Reagent is an approved product to be used in order to make decisions on the safety of drinking water and wastewater effluent.

 

· Canada, Alberta Energy Regulator, Directive 050: Drilling Waste Management (August 2019)

· Mexico, Mexican Standard NMX-AA-112SCFI-2017: Water and Sediment Analysis - Acute Toxicity Evaluation with Vibrio fischeri - Test Method

· Spain, International Standard Organization, ISO 11348-3: Water quality - Determination of the inhibitory effect of water samples on the light emission of Vibrio fischeri (Luminescent bacteria test) Part 3: Method using freeze- dried bacteria

· Italy, International Standard Organization, ISO 11348-3: Water quality - Determination of the inhibitory effect of water samples on the light emission of Vibrio fischeri (Luminescent bacteria test) Part 3: Method using freeze- dried bacteria

· Taiwan, Environmental Protection Agency, NIEA B301.10C: Determination of the acute toxicity - luminescent bacteria test

· United States, large municipalities rely on Microtox Acute Reagent for water quality testing such as drinking water effluent, including but not limited to Fairfax Water (Fairfax, VA) and LA Dept of Water (Los Angeles, CA).

 

 

Modern Water plc

Simon Humphrey, CEO

 

+44 (0)20 3827 3439

Cairn Financial Advisers LLP (Nominated Adviser)

 

Sandy Jamieson

Liam Murray

Ludovico Lazzaretti

+44 (0)20 7213 0880

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker / Zoe Alexander

+44 (0) 20 3621 4120

 

About Modern Water

Modern Water was established in 2006 to develop and commercialise water recovery technologies to counter water crisis problems arising from climate change and a growing global population. Having invested £20m over the last 14 years, the results comprise of a robust patent portfolio of cutting edge technology, focused on monitoring of contaminated water and decontamination of wastewater, making recycling of water more efficient. Six countries across the world have legislated that Modern Water monitoring test systems are written into their environmental protection legislation.

 

About Integumen plc

Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.

 

About University of York

The University of York is a collegiate research university, located in the city of York, England. Established in 1963, the university has expanded to more than thirty departments and centres. With over £8 million of capital equipment, 2,000 square meters of laboratories, the purpose-built centre of excellence provides access to state-of-the-art bioscience technologies for external academic laboratories and commercial business users. It has all the relevant equipment needed to begin production of the water contamination detection bacteria immediately.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPPUQPWUPUGWB
Date   Source Headline
5th Jun 20174:05 pmRNSNotification of Major Interest in Shares
5th Jun 20174:02 pmRNSNotification of Major Interest in Shares
1st Jun 20171:06 pmRNSPDMR Dealing
1st Jun 20178:00 amRNSNotification of Major Interest in Shares
30th May 20177:00 amRNSPDMR Dealing
25th May 201710:46 amRNSResult of Placing
25th May 20177:00 amRNSProposed Placing
28th Apr 20171:20 pmRNSPDMR Dealings
25th Apr 201711:23 amRNSResult of AGM
25th Apr 20177:00 amRNSNew VP of Global Sales and China Sales Manager
20th Apr 20177:00 amRNSSale of Seawater Desalination Technology in China
30th Mar 20174:29 pmRNSDirector Disclosure
15th Mar 20177:00 amRNSFinal Results
6th Feb 20177:00 amRNSFirst Sale of New Brine Concentration Technology
19th Dec 20168:03 amRNSSuccessful Pilot of new Brine Technology
6th Dec 20164:48 pmRNSHolding(s) in Company
30th Nov 20167:00 amRNSChange of Adviser
14th Nov 20167:00 amRNSDirector/PDMR Shareholding
14th Nov 20167:00 amRNSDirector/PDMR Shareholding
17th Oct 20167:00 amRNSModern Water receives order commitments in China
26th Sep 20167:00 amRNSDirector/PDMR Shareholding
15th Sep 20167:00 amRNSDirector/PDMR Shareholding
14th Sep 20161:41 pmRNSDirector/PDMR Shareholding
14th Sep 20167:00 amRNSHalf-year Report
14th Jun 20163:48 pmRNSHolding(s) in Company
26th Apr 20166:05 pmRNSResult of AGM
21st Mar 20167:00 amRNSJoint commercialisation agreement
16th Mar 20167:00 amRNSFinal Results
29th Jan 201612:53 pmRNSHolding(s) in Company
28th Jan 20167:00 amRNSJoint commercialisation agreement
9th Dec 20157:00 amRNSDirectorate Change
16th Nov 20157:00 amRNSModern Water Delivers Largest Monitoring Order
16th Sep 20157:00 amRNSINTERIM RESULTS
30th Apr 201511:23 amRNSResults of AGM
9th Apr 20157:00 amRNSAppointment of Chairman
11th Mar 20157:00 amRNSFinal Results
26th Jan 20157:00 amRNSModern Water installs first Microtox CTM in USA
12th Jan 20157:00 amRNSTrading Update
18th Dec 20147:00 amRNSDirectorate Change
6th Oct 20147:00 amRNSModern Water JV appointed as preferred bidder
17th Sep 20147:00 amRNSHalf Yearly Report
11th Aug 20149:42 amRNSModern Water launches new monitor - Replacement
11th Aug 20147:00 amRNSModern Water launces new hydrocarbon monitor
29th Jul 20149:50 amRNSModern Water targets Latin American market
6th May 201411:25 amRNSDirector/PDMR Shareholding
29th Apr 20147:00 amRNSModern Water launches new immunoassay strip test
23rd Apr 201410:57 amRNSResults of AGM
22nd Apr 201411:33 amRNSDirector/PDMR Shareholding
26th Mar 20147:00 amRNSSevern Trent trials Modern Water technology
17th Mar 201410:12 amRNSModern Water installs metal monitors in Argentina

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.